A phase I dose escalation study of AT9283, a small molecule...

Annals of Oncology 2012 / 05 Vol. 23; Iss. 5

A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies

Arkenau, H.- T., Plummer, R., Molife, L. R., Olmos, D., Yap, T. A., Squires, M., Lewis, S., Lock, V., Yule, M., Lyons, J., Calvert, H., Judson, I.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdr451
Date:
May, 2012
File:
PDF, 492 KB
english, 2012
Conversion to is in progress
Conversion to is failed